James P. Butler
Harvard University
H-index: 86
North America-United States
Top articles of James P. Butler
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Factors associated with COVID-19 infection in patients with behavioural and psychological symptoms of dementia. | Psychogeriatrics: the Official Journal of the Japanese Psychogeriatric Society | Masahiko Fujii James P Butler Hidetada Sasaki | 2024/3/17 |
The association of inflammation and chronic kidney disease with incident heart failure: a pooled cohort analysis | The American Journal of the Medical Sciences | A Hamid A Minhas M Tio MS Khan MS Usman | 2024/2/1 |
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial | Nature Communications | Peter Sandercock Janet Darbyshire David DeMets Robert Fowler David Lalloo | 2024/1/31 |
Prognostic implications of angiopoietin-2 in heart failure and the influence of empagliflozin: the EMPEROR program | European Heart Journal | J Butler | 2023/11 |
Trajectory of high sensitivity c-reactive protein and incident heart failure in black adults: the jackson heart study | The American Journal of the Medical Sciences | A Hamid W Yimer A Oshunbade MS Khan D Kamimura | 2023/2/1 |
Julius comroe is right: positive and negative pressure ventilation are the same | American Journal of Respiratory and Critical Care Medicine | James P Butler Robert B Banzett Stephen H Loring | 2023/7/15 |
Effects of empaglifozin on collagen biomarkers in patients with heart failure. Results from the EMPEROR trials | European Heart Journal | J Ferreira M Sumin J Butler F Zannad | 2023/11 |
Delightful Aging for Geriatric Patients. J Alzheimer’s Neurodegener Dis 9: 61 | of | M Fujii JP Butler H Sasaki | 2023 |
RITUXIMAB‐CONTAINING COMBINED MODALITY THERAPY IN LIMITED STAGE FOLLICULAR LYMPHOMA: MATURE FOLLOW UP AND DERIVATION OF A NOVEL PROGNOSTIC SCORE FROM THE TROG99. 03 TRIAL | Hematological Oncology | JW Tobin V Jurinovic H Tsang D Roos R Tsang | 2023/6 |
Diuretic use and outcomes in patients with HFrEF: Insights from the VICTORIA trial | European Heart Journal | JA Ezekowitz W Alemayehu F Edelmann P Ponikowski CSP Lam | 2023/11 |
2021 Рекомендации ESC по диагностике и лечению острой и хронической сердечной недостаточности | Российский кардиологический журнал | TA Mcdonagh M Metra M Adamo RS Gardner A Baumbach | 2023 |
CO184 US Population Burden of Acute Heart Failure Events and Hospitalization in Patients with Recent Worsening Heart Failure and Left Ventricular Ejection Fraction≤ 30% | Value in Health | NR Desai DRJ Gomes T Wang Y Deng HP Goertz | 2023/6/1 |
Baseline characteristics of patients enrolled in the EMPACT-MI trial | European Heart Journal | J Butler | 2023/11 |
Impact of Supine Versus Semirecumbent Body Posture on the Distribution of Ventilation in Acute Respiratory Distress Syndrome | Critical Care Explorations | Alex K Pearce W Cameron McGuire Ann R Elliott Ewan C Goligher G Kim Prisk | 2023/12/1 |
Mechanisms underlying efficacy of acetazolamide for sleep apnea in patients with heart failure | SA Sands BA Edwards RL Owens PN Deyoung D McSharry | 2023/5 | |
Bowling, B 99 Bradford, B 95n Braithwaite, J 40, 54, 68-70, 153, 154n, 174n Braithwaite, V 174n | Criminology as a Moral Science | D Braman T Asad L Brangan J Attanucci JL Austin | 2023/9/7 |
Effect of vericiguat on cardiovascular outcomes in patients with heart failure with and without diabetes: Insights from the VICTORIA trial | European Heart Journal | S Khan J Butler R Young BS Lewis J Escobedo | 2023/11 |
Traditional Chinese medicine Jia Wei Gui Pi Tang improves behavioural and psychological symptoms of dementia and favourable positive emotions in patients | Psychogeriatrics | Tatsuya Nogami Koh Iwasaki Hideo Kimura Toru Higashi Makoto Arai | 2023/5 |
Efficacy and Safety of Empagliflozin According to Background Diuretic Use in Heart Failure With Reduced Ejection Fraction: Post-Hoc Analysis of EMPEROR-Reduced. | Heart Failure | Nitish K Dhingra Subodh Verma Javed Butler Stefan D Anker Joao Pedro Ferreira | 2024/1/1 |
Effects of empagliflozin in patients with heart failure and preserved ejection fraction according to baseline diuretic use: results from the EMPEROR-Preserved trial | European Heart Journal | J Butler | 2022/10/1 |
Co-Authors
